Experimental intravitreal application of ciprofloxacin in rabbits

Ophthalmologica

Volumn 213, Issue 2, 1999, Pages 120-128

  Wiechens, Burkhard ^a   Grammer, Joachim B ^b   Johannsen, Ute ^a   Pleyer, Uwe ^c   Hedderich, Jürgen ^a   Duncker, Gernot I W ^d  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Antibiotic; Ciprofloxacin; Fluoroquinolones; Intravitreal injection; Retinal toxicity

Indexed keywords

CIPROFLOXACIN;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; ELECTRORETINOGRAM; FOLLOW UP; INTRAVITREAL DRUG ADMINISTRATION; NONHUMAN; RABBIT; RETINOPATHY; TOXICITY TESTING;

ANIMALS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; ELECTRORETINOGRAPHY; FOLLOW-UP STUDIES; LIPOSOMES; MALE; PILOT PROJECTS; RABBITS; RETINA; VITREOUS BODY;

EID: 0033007228     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000027404     Document Type: Article

References (81)

1. Bartz-Schmidt KU, Bermig J, Kirchhoff B, Wiedemann P, Walter P, Heimann K: Prognostic factors associated with the visual outcome after vitrectomy for endophthalmitis. Graefe's Arch Clin Exp Ophthalmol 1996;234: 51-58.
2. Barzilai A, Elchalil G, Joseph G, Rubinstein E: The penetration of ciprofloxacin (CIP) into the human vitreous. Abstr 2nd Int Symp New Quinolones, Geneva Aug 1988, p 104.
3. El Baba FZ, Gauderman WJ, Wagner DG, Liggett PE: Intravitreal penetration of oral ciprofloxacin in humans. Ophthalmology 1992;99: 483-486.
4. Endophthalmitis Vitrectomy Study Group: Results of the endophthalmitis vitrectomy study: A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995;113:1479-1496.
5. Keren G, Alhalel A, Bartov E, Kitzes-Cohen R, Rubinstein E: The intravitreal penetration of orally administered ciprofloxacin in humans. Invest Ophthalmol Vis Sci 1991;32:2388-2392.
6. Lesk MR, Amman H, Marcil G, Vinet B, Lamer L: The peretration of oral ciprofloxacin into the aqueous humor, vitreous and subretinal fluid of humans. Am J Ophthalmol 1993; 115:623-628.
7. O'Brien TP, Osterhout G, Dick JD: Comparative ocular penetration of topical ofloxacin and ciprofloxacin in rabbits. Invest Ophthalmol Vis Sci 1993;34:859.
8. Yeo JH, O'Brien TP, Green WR, Johnson MA, Greenberg KA, Gottsch JD: Ciprofloxacin: Oral penetration into the eye and retinal toxicity of intravitreal injection. Invest Ophthalmol Vis Sci 1989;30:381.
9. Camprochiaro PA, Lim JL, the Aminoglycoside Toxicity Study Group: Aminoglycoside toxicity in the treatment of endophthalmitis. Arch Ophthalmol 1994;112:48-53.
10. Rosenbaum JD, Krumholz DM, Metz DM: Gentamicin retinal toxicity after cataract surgery in an eye that underwent vitrectomy. Ophthalmol Surg Laser 1997;28:236-238.
11. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, Fukuchi Y, Kobayashi I: Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997;350:1670-1673.
12. Cokingtin CD, Hyndiuk RA: Insights from experimental data on ciprofloxacin in the treatment of bacterial keratitis and ocular infections. Am J Ophthalmol 1991;112:25-28.
13. Insler MS, Fish LA, Silbernagel J, Hobden JA, O'Callaghan RJ, Hill JM: Successful treatment of methicillin-resistant Staphylococcus aureus keratitis with topical ciprofloxacin. Ophthalmology 1991;98:1690-1692.
14. Kaufman AH, Darrell RW, Shieh E, Landzberg B, Fay AM, Chin NX: Treatment of methicillin-resistant Staphylococcus aureus keratitis in rabbits with ciprofloxacin, norfloxacin, ofloxacin, Vancomycin and cefazolin. Invest Ophthalmol Vis Sci 1991;32:1171.
15. Leibowitz HM: Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis. Am J Ophthalmol 1991;112:29-33.
16. Leibowitz HM: Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol 1991;112:34-47.
17. Reidy JJ, Hobden JA, Hill JM, Forman K, O'Callaghan RJ: The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental pseudomonas keratitis. Cornea 1991;10:25-28.
18. Jensen HG, Stevens SX, Fouraker BD, Gherezgiher T, Nordquist RE: Retinal toxicity of ciprofloxacin. Abstr 29th Intersci Conf Antimicrob Agents Chemother, Houston, Sept 1989, p 151.
19. Kim SH, Kim HG, Cho KS, Kwak JS: Safety of intravitreally injected ciprofloxacin. Korean J Ophthalmol 1995;9:12-18.
20. Marchese AL, Slana VS, Holmes EW, Jay WM: Toxicity and pharmacokinetics of ciprofloxacin. J Ocul Pharmacol 1993;9:69-76.
21. Parks DJ, Snyder ME, Cytryn AS, Katz HR: Retinal toxicity of intravitreal ciprofloxacin in a rabbit model. Invest Ophthalmol Vis Sci 1992;33:747.
22. Rootman DS, Savage P, Hasany SM, Chisholm L, Basu PK: The toxicity and pharmacokinetics of intravitreal ciprofloxacin in rabbit eyes. Can J Ophthalmol 1992;27:277-282.
23. Slana VS, Marchese AL, Jay WM: Oculartoxicity of intravitreal ciprofloxacin injection in pigmented rabbit eyes. Invest Ophthalmol Vis Sci 1992;33:727.
24. Stevens SX, Fouraker BD, Jensen HG: Intraocular safety of ciprofloxacin. Arch Ophthalmol 1991;109:1737-1743.
25. Barza M: Antibacterial agents in the treatment of ocular infections. Infect Dis Clin North Am 1989;3:533-551.
26. Barza M: Use of quinolones for treatment of ear and eye infections. Eur J Clin Microbiol Infect Dis 1991;10:296-303.
27. Neu HC: Microbiologic aspects of fluoroquinolones. Am J Ophthalmol 1991;112(suppl 4): 15S-24S.
28. Role of fluoroquinolones in ophthalmology. Int Ophthalmol Clin 1993;33:162-178.
29. Wiechens B, Duncker G, Johannsen U, Burkhart M: Retinotoxicity of intravitreal ciprofloxacin in rabbit eyes. Invest Ophthalmol Vis Sci 1993;34(suppl 4):1425.
30. Kaplan HJ, Cytryn AS, Parks DJ, Katz HR: Vitreous levels of ciprofloxacin after intravitreal injection in the rabbit. Invest Ophthalmol Vis Sci 1992;33:729.
31. Katz HR, Cytryn AS, Parks DJ: Aqueous and vitreous levels of ciprofloxacin after subconjunctival injection in the rabbit. Invest Ophthalmol Vis Sci 1992;33:1014.
32. Pearson PA, Hainsworth DP, Ashton P: Clearance and distribution of ciprofloxacin after intravitreal injection. Retina 1993;13:326-330.
33. Bangham AD, Standish MM, Watkins JC: Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965;13: 238-252.
34. Bedard J, Bryan LE: Interaction of the fluoroquinolone antimicrobial agents ciprofloxacin and enoxacin with liposomes. Antimicrob Agents Chemother 1989;33:1379-1382.
35. Coune A: Liposomes as drug delivery system in the treatment of infectious diseases: Potential applications and clinical experience. Infection 1988;16:141-147.
36. Alghadyan AA, Peyman GA, Khoobehi B, Liu K-R: Liposome-bound cyclosporine: Retinal toxicity after intravitreal injection. Int Ophthalmol 1988;12:105-107.
37. Alghadyan AA, Peyman GA, Khoobehi B, Milner S, Liu K-R: Liposome-bound cyclosporine: Clearance after intravitreal injection. Int Ophthalmol 1988;12:109-112.
38. Barza M, Baum J, Tremblay C, Szoka F, d'Amico DJ: Ocular toxicity of intravitreally injected liposomal amphotericin B in rhesus monkeys. Am J Ophthalmol 1985;100:259-263.
39. Fishman PH, Peyman GA, Cesar T: Intravitreal liposome-encapsulated gentamicin in a rabbit model. Invest Ophthalmol Vis Sci 1986; 27:1103-1106.
40. 3H-5FU in rabbits. Int Ophthalmol 1989;13:361-365.
41. Liu K-R, Peyman GA, Khoobehi B, Alkan H, Fiscella R: Intravitreal liposome-encapsulated trifluorothymidine in a rabbit model. Ophthalmology 1987;94:1155-1159.
42. Liu K-R, Peyman GA, She SCH, Niesman MR, Khoobehi B: Intravitreally injected liposome-encapsulated cytarabine. Ophthalmic Surg 1989;20:358-360.
43. Peyman GA, Khoobehi B, Tawakol M, Schulman JA, Mortada HA, Alkan H, Fiscella R: Intravitreal injection of liposome-encapsulated ganciclovir in a rabbit model. Retina 1987;7: 227-229.
44. Peyman GA, Khoobehi B, Tawakol M, Schulman JA, Mortada HA, Alkan H, Fiscella R: Toxicity and clearance of a combination of liposome-encapsulated ganciclovir and trifluridine. Retina 1989;9:232-236.
45. Tremblay C, Barza M, Szika F, Lahav M, Baum J: Reduced toxicity of liposome-associated amphotericin B injected intravitreally in rabbits. Invest Ophthalmol Vis Sci 1985;26: 711-718.
46. Grammer JB: Topische Applikation von Liposomen als Medikamententräger in der Ophthalmologie: In-vitro- und In-vivo-Untersuchungen zum Einfluss physiko-chemischer Eigenschaften der Liposomen auf die okuläre Pharmakokinetik; Dissertation, Fakultät für Biologie, Eberhard-Karls-Universität Tübingen, 1997.
47. New RCC: Liposomes: A Practical Approach. Oxford, IRL Press, Oxford University Press, 1994, pp 33-104.
48. Heine U: Beitrag zur Anästhesie von Kaninchen. Klin Monatsbl Augenheilkd 1982;181: 195-196.
49. Nozaki S, Wakakura M, Ishikawa S: Circadian rhythm of human electroretinograms. Jpn J Ophthalmol 1983;27:346-352.
50. Spivey BE, Pearlman JT: Day-to-day variations in the ERG of humans and rabbits. Am J Ophthalmol 1963;55:1013-1020.
51. Bredehorn T: Ein neues Messsystem für elektroretinographische Potentiale im tierexperimentellen Versuch; Dissertation, Medizinische Fakultät, Christian-Albrechts-Universität zu Kiel, 1993.
52. Schmiederer M: Vergleichende elektroretinographische und morphologische Untersuchung der Rattenretina nach oraler Gabe des lipidoseinduzierenden Pharmakons Chloroquin; Dissertation, Medizinische Fakultät, Christian-Albrecht-Universität zu Kiel, 1993.
53. Dixon WJ, Brown MB, Engelman L, Jennrich RI: BMDP Statistical Software Manual. Vol 1 + 2. Berkeley, University of California Press, 1990.
54. Ogawa GSH, Hyndiuk RA: The fluoroquinolones: New antibiotics in ophthalmology. Int Ophthalmol Clin 1993;33:59-68.
55. Chan PY, Leung YK, Ng WWS: Comparative in vitro antibacterial activity of ofloxacin and ciprofloxacin against some selected gram-positive and gram-negative isolates. Infection 1986; 14(suppl 4):237-239.
56. Goldstein EJG, Citron DM, Bendon L, Vagvolgyi AE, Trousdale MD, Appleman MD: Potential of topical norfloxacin therapy. Arch Ophthalmol 1987;195:991-994.
57. Osato MS, Jensen HG, Trousdale MD, Bosso JA: The comparative in vitro activity of ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates. Am J Ophthalmol 1989;108:380-386.
58. Petrikkos G, Kanellas D, Giamarallou H, Kavouklis E, Chryssoulis Z, Gabriel L: Comparative humor kinetics of ciprofloxacin, ofloxacin and pefloxacin into the human eye. Eur J Clin Microbiol Infect Dis 1991;10:39-40.
59. Behrens-Baumann W, Martell J: Ciprofloxacin concentration in human aqueous humor following intravenous administration. Chemotherapy 1987;33:328-330.
60. Behrens-Baumann W, Martell J: Ciprofloxacin concentration in the rabbit aqueous humor and vitreous body following intravenous and subconjunctival administration. Infection 1998; 16:62-65.
61. Kurt P, Federspil P, Tiesler E, Altmeyer P: Experimentelle Untersuchungen zur Pharmakokinetik von Ciprofloxacin. Fortschr Antimikrob Antineoplast Chemother (FAC) 1989;8: 143-146.
62. Mounier M, Adenis JP, Denis F: Pénétration intraoculaire de la ciprofloxacine après perfusion et prise orale. Pathol Biol 1988;36:724-727.
63. Weisse I: Microscopical examination of the eye. 1.3.1.1 Perfusion fixation; in Hockwin O, Green K, Rubin LF (eds): Manual of Oculotoxicity Testing of Drugs. Stuttgart, Fischer, 1992, p 143.
64. Nicolai U: Histologische Untersuchung zur In-vivo-Fixierung von Kaninchennetzhaut. Ophthalmologe 1993;90(suppl 1):131.
65. D'Amico DJ, Libert J, Kenyon KR, Hanninen LA, Caspers-Velu L: Retinal toxicity of intravitreal gentamicin. Invest Ophthalmol Vis Sci 1984;25:564-572.
66. Fukuda M, Sasaki K: The influence of melanin on intraocular dynamics. Acta Soc Ophthalmol Jpn 1988;92:1839-1843.
67. Fukuda M, Sasaki K: Intraocular dynamic mode differences of new quinolone antibacterial agents between pigmented and albino rabbit eyes. Lens Eye Toxicity Res 1989;6:339-351.
68. Fukuda M, Sasaki K: Intraocular penetration of norfloxacin into the pigmented rabbit eye. Atarashii Ganka 1993;10:431-434.
69. D'Amico DJ, Caspers-Velu L, Libert J, Shanks E, Sdrooyen M, Hanninen LA, Kenyon KR: Comparative toxicity of intravitreal aminoglycoside antibiotics. Am J Ophthalmol 1985;100: 264-275.
70. Lüllmann-Rauch R: Drug-induced lysosomal storage disorders; in Dingle JT, Jaques PJ, Shaw IH (eds): Lysosomes in Applied Biology and Therapeutics. Amsterdam, North-Holland Publishing Co, 1979, pp 49-130.
71. Lüllmann-Rauch R, Lüpkes S: Drug-induced degeneration of photoreceptorcells. Adv Biosci 1987;62:471-476.
72. Cytryn AS, Kaufman G, Parks DJ, Goldman EJ, Katz HR: The role of early vitrectomy and intravitreal ciprofloxacin in the management of Staphylococcus aureus endophthalmitis in the rabbit. Invest Ophthalmol Vis Sci 1992;33 (suppl 4):747.
73. Greenberg KA, O'Brien TP, Yeo JH, Dick JD, Gottsch JD: Treatment of experimental endophthalmitis with intravitreal ciprofloxacin. Invest Ophthalmol Vis Sci 1989;30:199.
74. Katz HR, Cytryn AS, Parks DJ: Treatment of Pseudomonas aeruginosa endophthalmitis in a rabbit model with intravitreal ciprofloxacin. Invest Ophthalmol Vis Sci 1991;32:706.
75. Liss RA, Kaplan HJ, Awh CC, Snyder ME, Katz HR: Treatment of experimental Staphylococcus epidermidis endophthalmitis with intravitreal ciprofloxacin. Invest Ophthalmol Vis Sci 1993;34:1260.
76. Rao VS, Peyman GA, Khoobehi B, Vangipuram S: Evaluation of liposome-encapsulated clindamycin in Staphylococcus aureus endophthalmitis. Int Ophthalmol 1989;13:181-185.
77. Magallanes M, Dijkstra J, Fierer J: Liposome-incorporated ciprofloxacin in treatment of murine salmonellosis. Antimicrob Agents Chemother 1993;37:2293-2297.
78. Majumdar S, Flasher D, Friend DS, Nassos P, Yajko D, Hadley WK, Duzgunes N: Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages. Antimicrob Agents Chemother 1992;36:2808-2815.
79. Oh Y-K, Nix DE, Straubinger RM: Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection. Antimicrob Agents Chemother 1995;39:2104-2111.
80. Onyegji CO, Nightingale CH, Nicolau DP, Quintiliani R: Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages. Antimicrob Agents Chemother 1994;38:523-527.
81. Peyman GA, Charles HC, Liu R, Khoobehi B, Niesman M: Intravitreal liposome-encapsulated drugs: A preliminary human report. Int Ophthalmol 1988;12:175-182.